Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device

Go back to Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
(NASDAQ: COCH) Delayed: 0.71 +0.03 (4.41%)
Previous Close $0.68    52 Week High
Open $0.67    52 Week Low
Day High $0.71    P/E N/A 
Day Low $0.67    EPS
Volume 48,510